Patent · US Active

Anti-IFNAR1 antibodies with reduced Fc ligand affinity

US10301390B2 · kind B2 · utility

1Cited by
4References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 4, 2018
Grant dateMay 28, 2019
Priority date—
Expiry dateMay 4, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides anti-IFNAR1 antibodies with reduced affinity for Fc receptors and/or ligands and methods of making and using such antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.